內媒稱小米(01810.HK)正加大明年零部件訂單量 冀搶市場份額
內地傳媒引述消息人士指,小米(01810.HK)正加大明年零部件訂單數量,報道指公司一直與供應商洽淡,預訂高達2.4億部手機的零部件,不僅超越小米今年產量,更超蘋果iPhone的平均年出貨量,意味小米已設計明年超越華為的目標。
知情人士透露小米向部分供應商指,內部有更高目標,期望明年銷量高達3億台,不過晶片供應商高通(QCOM.US)及聯發科均未能承諾如此大的訂單,而小米則期望在其他競爭對手趕上之前擴大市場份額,故希望預訂更多零部件,以避免當前供應鏈瓶頸和零部件短缺造成的任何生產中斷。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.